Etteplan: Looking quite good despite headwinds - Evli Research

Despite a below expectations Q4, at least partly due to increased sickness-related absences, we see slightly improving expectations for 2023. We adjust our target price to EUR 16.0 (15.0), HOLD-rating intact.

Länk till analysen i sin helhet: https://www.evli.com/hubfs/ERP/Raportit/Etteplan/Etteplan%20230220%20Q4%20Company%20update.pdf